- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pethema
Total 100 results
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationBristol-Myers Squibb; Celgene; Adknoma Health Research, S.L.TerminatedMultiple MyelomaSpain
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
PETHEMA FoundationCelgene; Janssen-Cilag Ltd.; TFS Trial Form SupportCompleted
-
PETHEMA FoundationJanssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.Completed
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationBristol-Myers Squibb; Dynamic SolutionsUnknownChronic Myeloid LeukemiaSpain
-
PETHEMA FoundationTerminated
-
PETHEMA FoundationCompletedAcute Lymphoblastic Leukemia | Burkitt's LymphomaSpain
-
PETHEMA FoundationCompletedAcute Promyelocytic LeukemiaSpain, Uruguay, Poland
-
PETHEMA FoundationCompletedAcute Lymphoblastic LeukemiaSpain
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompletedAcute Promyelocytic LeukemiaSpain
-
PETHEMA FoundationRoche Pharma AG; Celgene CorporationTerminatedMyelodysplastic SyndromeSpain
-
PETHEMA FoundationTerminatedDiabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSFSpain
-
PETHEMA FoundationGrupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y MielodisplasiasTerminatedAcute Myelogenous LeukemiaSpain
-
PETHEMA FoundationCelgene CorporationCompleted
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompletedLymphoma | Lymphoblastic LeukemiaSpain
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research...Completed
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompletedAcute Myeloblastic LeukaemiaSpain
-
PETHEMA FoundationCompletedAcute Lymphoblastic LeukemiaSpain
-
PETHEMA FoundationCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerPETHEMA (Program for the Study and Treatment of Haematological Malignances)CompletedLymphoma | Leukemia | Stem Cell Transplantation | Myelodysplasia | Myeloma | Hematological MalignancySpain
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationMerck Sharp & Dohme LLCCompleted
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompletedAcute Lymphoblastic LeukemiaSpain
-
PETHEMA FoundationGTEI; SEMICYUCCompletedCandidiasis | AspergillosisSpain
-
PETHEMA FoundationCompletedFebrile Neutropenia | Allogenic Blood Stem Cell TransplantationSpain
-
PETHEMA FoundationCompletedAcute Myeloid Leukemia | Allogeneic Haematopoietic Progenitor Cell TransplantSpain
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCompletedMyelodysplastic SyndromeSpain
-
PETHEMA FoundationCompletedMyelodysplastic Syndrome | Acute Myeloblastic LeukemiaSpain
-
PETHEMA FoundationCompletedAcute Lymphoblastic Leukemia | Cromosome Philadelphia PositiveSpain
-
PETHEMA FoundationCompletedAcute Myeloid LeukemiaSpain
-
PETHEMA FoundationCompletedAcute Promyelocytic LeukemiaSpain